CAR-Like T Cells Enhance Tumor Response in Gastroesophageal Cancer
(MedPage Today) -- SAN FRANCISCO -- The response rate in metastatic gastroesophageal cancer improved by a relative 50% when patients ...
(MedPage Today) -- SAN FRANCISCO -- The response rate in metastatic gastroesophageal cancer improved by a relative 50% when patients ...
(MedPage Today) -- SAN FRANCISCO -- Incorporating the recently approved bispecific antibody zanidatamab (Ziihera) into first-line treatment for HER2-positive gastroesophageal ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.